ADC Therapeutics Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, ADC Therapeutics stock has a consensus rating of "Buy" and an average price target of $5.00. The average 1-year stock price forecast is 287.60% higher than the current stock price, while the lowest is $2.00 (+55.04%) and the highest is $10 (+675.19%).

Price Target: $5.00 (+287.60%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$5.00	$3.00	$10
Change	+55.04%	+287.60%	+132.56%	+675.19%

Analyst Ratings

The average analyst rating for ADC Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	5	5	5	5	3	3
Buy	1	1	1	1	0	0
Hold	0	0	0	0	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Schmidt Guggenheim	Guggenheim	Buy Initiates $10	Buy	Initiates	$10	+675.19%	Jul 1, 2026
Leonid Timashev RBC Capital	RBC Capital	Hold Maintains $2	Hold	Maintains	$2	+55.04%	Jun 24, 2026
Robert Burns H.C. Wainwright	H.C. Wainwright	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 8, 2026
Sudan Loganathan Stephens	Stephens	Buy Reiterates $5	Buy	Reiterates	$5	+287.60%	Jun 4, 2026

Financial Forecast

Revenue This Year

80.89M

from 81.36M

-0.57%

from 81.36M

Revenue Next Year

123.82M

from 80.89M

53.07%

from 80.89M

EPS This Year

1.02

from -

EPS Next Year

2.27

from 1.02

122.55%

from 1.02

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	33.92M	209.91M	69.56M	70.84M	81.36M	80.89M
Revenue Growth	-	518.89%	-66.86%	1.84%	14.85%	-0.57%
Operating Income	-261.72M	-123.34M	-165.99M	-129.14M	-106.10M	-94.97M
Net Income	-230.03M	-157.13M	-240.05M	-157.85M	-142.62M	-136.13M
EPS	-	-	-	-	-	1.02
Forward PE	-	-	-	-	-	1.26
Free Cash Flow	-141.90M	-72.93M	-79.93M	-70.85M	-103.81M	-166.00M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	85.8M
Avg	80.9M
Low	73.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	5.5%
Avg	-0.6%
Low	-9.8%

EPS Forecast

EPS	2026	2027	2028
High	1.02
Avg	1.02
Low	1.02

EPS Growth

EPS Growth	2027	2028
High	122.5%
Avg	122.5%
Low	122.5%